CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products.
Returning for its 6th year, the Microbiome Movement – Animal Health & Nutrition Summit remains the definitive forum for animal feed and therapeutic developers across livestock and companion animals to join microbiome industry colleagues and gain scientific and practical clarity to make the animal microbiome a successful addition to product portfolios.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
